Friday, November 3, 2023
10:30-14:30 Central European Time (CET)
Welcome Note
Yuval Yaron, Israel
Sponsored symposium- Illumina
Prenatal Genomic Sequencing: improving diagnostic yield and aiding clinical utility
Mark Kilby, UK
Session 1: Advances in Prenatal Diagnosis
The diagnostic yield of prenatal exome sequencing in structurally normal fetuses
Hagit Daum, Israel
NGS Based newborn screening
David Bick, UK
Somatic mutation causing megalencephaly
Ritsuko Kimata Pooh, Japan
The use of Optical Genome Mapping in Prenatal Diagnosis
Brynn Levy, USA
Session 2: Non-Invasive Prenatal testing
TRIDENT2 results and conclusions
Erik Sistermans, The Netherlands
The use of cfDNA to screen for monogenic conditions in low risk populations
Neeta Vora, USA
Cell-Based Non-invasive Prentatal Testing – Is it still a Distant Star?
Ripudaman Singh, Denmark
NIPT for sex chromosome abnormalities global practices and ethical implication
Ida Vogel, Denmark
Saturday, November 4, 2023
10:30-14:30 Central European Time (CET)
Sponsored symposium- Revvity
Moderator: Yuval Yaron, Israel
From samples to outcomes, one Canadian laboratory’s experience with the Vanadis NIPT platform
Jean Gekas, Canada
The benefits and pitfalls of using PPV for NIPT clinical interpretation
Lawrence Prensky, Revvity
Session 3: Preimplantation genetic testing (PGT)
Ex Utero Embryogenesis: Naive Pluripotent Stem-cells-derived Embryoid Models (SEMs)
Yaqub Hanna, Israel
Whole genome PGT for transmitted and de novo mutations, using whole genome sequencing (PGT-WGS) with GenomeScreen®
Santiago Munne, Spain
How close are we to universal PGT
Tony Gordon, UK
Pathways leading to segmental aneuploidy
Joris Vermeesch, Belgium
Genetic Impacts on IVF Embryo Viability
Rajiv McCoy, USA
Eliminating pathogenic genes: Gene editing (CRISPR) vs. PGT-M
Avner Hershlag, USA
Congress summary and Highlights
Yuval Yaron, Israel